A long-term observational study has found that individuals who return to normal blood sugar levels after a prediabetes diagnosis face a 58% lower risk of death from cardiovascular disease or hospitalisation for heart failure, and a 42% lower risk of major cardiovascular events such as heart attack and stroke, compared with those who remain prediabetic. The protective effect persisted for decades, researchers reported, positioning blood sugar normalisation alongside blood pressure control and smoking cessation as a central goal of cardiovascular prevention. More than one billion people worldwide are estimated to have prediabetes.

British clinicians have issued a caution about the growing online market for unregulated injectable peptides sold for muscle growth, anti-ageing and fat loss. Women are particularly vulnerable, they note, because sex-based differences in drug metabolism, hormonal sensitivity and immune response make adverse reactions one and a half to two times more likely. Peptides such as ipamorelin and CJC-1295 artificially elevate growth hormone and IGF-1, disrupting ovarian function and raising miscarriage risk, while a synthetic fragment of thymosin beta-4, found in several cancers, is marketed as a tissue-repair aid without safety data. Separately, Mexican researchers tracking 248 mother–child pairs for two years found that infants consuming seven grams or more of added sugar daily had waist circumferences about two centimetres larger and less favourable length-for-age growth than those who avoided added sugars. Sugar exposure rose from near zero at six months to a median of 19.4 grams per day by age two; breastfeeding beyond three months significantly reduced intake.

Access to continuous care remains uneven. In Sweden, a report from the District Medical Association shows that fewer than half the population has a named family doctor, with the average general practitioner responsible for 2,400 patients—more than double the official guideline of 1,100. The shortage is most acute in Kronoberg county, where each doctor covers 3,342 residents, leaving elderly and chronically ill patients without the continuity that aids diagnosis. In Mexico, researchers from the National Autonomous University presented data showing that women over 65 bear a higher burden of chronic illness—40% have hypertension versus 30% of men—yet their average incomes fall below the national mean in 85% of the country, restricting their ability to pay for care. Women also perform the bulk of unpaid caregiving for older adults, compounding their own health vulnerability.

Technology and communication are being deployed to bridge some gaps. In Brazil and the United States, more than 40% of adults now use wearable devices that track heart rate, glucose or oxygenation, but cardiologists stress these serve only as triage tools, not diagnostic instruments. In Malaysia, where only 35% of eligible women had undergone cervical cancer screening despite decades of free programmes, researchers at the National University of Malaysia developed an emotion-driven video that reduced fear and confusion, making viewers feel supported and empowered—a design principle now being considered for other public health campaigns. The next milestones to watch include regulatory moves to curb grey-market peptide sales, the implementation of Sweden’s legislated right to a fixed doctor, and Mexico’s debate on formally recognising and supporting family caregivers.